Abstract:Objective To compare the effects of laparoscopic sleeve gastrectomy ( LSG ) and laparoscopic Roux-en-Y gastric bypass ( LRYGB) on pulmonary function and blood lipid levels in patients with severe obesity. Methods 90 patients with severe obesity ( BMI ≥ 35kg/m2 ) admitted to two hospitals from November 2014 to November 2017 were analyzed retrospectively , and the patients were treated with LSG (n=48) or LRYGB (n=42).The SPSS 19.0 was used for statistical analysis , and the general data, lung function indexes, physiological indexes and blood lipid levels were compared by (xˉ±s).The independent t test or one-way ANOVA was used for comparison between groups .The enumeration data was tested by χ2 .P<0.05 indicated that the statistical difference was significant . Results The surgical and anesthesia durations in LSG group were lower than those in LRYGB group , and the differences were statistically significant (P<0.05).And the amount of blood loss during surgery between the two groups showed no statistically significant difference (P>0.05).There was no significant difference in lung function between the groups before surgery.The levels of PaO2 , FVC, FEV1 and MMF in both groups were allsignificantly decreased after surgery (P <0.05).The levels of PaO2 , FVC, FEV1 and MMF in both groupsat 48 h after surgery were all significantly improved than those at 24 h after surgery (P <0.05), but werestill significantly lower than those before surgery (P <0.05).The levels of PaO2 , FVC, FEV1 and MMF inLSG group were all higher than those in LRYGB group at 24 h and 48 h after surgery, and the differenceswere statistically significant ( P <0.05). The levels of weight, BMI, waist circumference, hipcircumference, fasting blood glucose and 2-hour postprandial blood glucose in both groups at 6 months aftersurgery were all decreased than those before surgery, and the differences were statistically significant(P <0.05); however, there was no statistically significant difference between the two groups (P >0.05).The levels of TG, CH and LDL in both groups at 6 months after surgery were significantly decreased thanthose before surgery, while the HDL level was significantly increased (P <0.05); however, there was nostatistically significant difference between the two groups (P >0.05). Conclusion LRYGB and LSGhave the similar result in weight loss and have no significant difference in improving blood lipids , but LSGhas less effects on short-term lung function and oxygenation compared with LRYGB .

Baseline of visceral fat area and decreased body weight correlate with improved pulmonary function after Roux-en-Y Gastric Bypass in Chinese obese patients with BMI 28–35 kg/m2 and Type 2 diabetes: a 6-month follow-up

Effect of Roux-en-Y Gastric Bypass on Remission of T2D: Medium-Term Follow-up in Chinese Patients with Different BMI Obesity Class

Metabolic Effects and Safety of Roux‐en‐Y Gastric Bypass Surgery Vs. Conventional Medication in Obese Chinese Patients with Type 2 Diabetes

Chenodeoxycholic Acid As a Potential Prognostic Marker for Roux-en-Y Gastric Bypass in Chinese Obese Patients.

Analysis of long-term outcome of modified gastric bypass for type 2 diabetes mellitus in Chinese patients

Quality of life after Roux-en-Y gastric bypass and changes in body mass index and obesity-related comorbidities

Body Adiposity Index Is Predictive Of Weight Loss After Roux-En-Y Gastric Bypass

Serum Stearic Acid/palmitic Acid Ratio As a Potential Predictor of Diabetes Remission after Roux‐en‐Y Gastric Bypass in Obesity

Cost-Utility of Laparoscopic Roux-en-Y Gastric Bypass in Chinese Patients with Type 2 Diabetes and Obesity with a BMI ≥ 27.5 Kg/m2: a Multi-Center Study with a 4-Year Follow-Up of Surgical Cohort

Changes in Nutritional Outcomes After Roux-en-Y Gastric Bypass: A Systematic Review and Meta-Analysis

Preoperative Fasting C-Peptide Predicts Type 2 Diabetes Mellitus Remission in Low-BMI Chinese Patients After Roux-en-Y Gastric Bypass

2008-P: Roux-en-Y Gastric Bypass Surgery Can Modulate ER Stress and Inflammation on Subcutaneous Adipose Tissue in Nondiabetic Patients with Obesity

Associations of change in body fat percentage with baseline body composition and diabetes remission after bariatric surgery

Poor diet quality is associated with biochemical parameters of protein nutritional status after Roux-en-Y gastric bypass

Relationship between Body Adiposity Indices and Reversal of Metabolically Unhealthy Obesity 6 Months after Roux-en-Y Gastric Bypass

Analysis of Changes in Pulmonary Function and Blood Lipid Levels in Patients with Severe Obesity after Laparoscopic Sleeve Gastrectomy and Laparoscopic Roux-en-Y Gastric Bypass

Impact of gastric bypass surgery on the liver fibrosis of patients with extreme obesity and nonalcoholic fatty liver disease in 30-month follow-up

Increased Energy Expenditure and Energy Loss Through Feces Contribute to the Long-Term Outcome of Roux-en-Y Gastric Bypass in a Diet-Induced Obese Mouse Model

Long-term outcomes of Roux-en-Y gastric bypass versus medical therapy for patients with type 2 diabetes: a meta-analysis of randomized controlled trials

Long-term Changes in Weight Loss and Obesity-Related Comorbidities after Roux-en-Y Gastric Bypass: a Primary Care Experience.